Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Central insulin action in energy and glucose homeostasis
Leona Plum, … , Bengt F. Belgardt, Jens C. Brüning
Leona Plum, … , Bengt F. Belgardt, Jens C. Brüning
Published July 3, 2006
Citation Information: J Clin Invest. 2006;116(7):1761-1766. https://doi.org/10.1172/JCI29063.
View: Text | PDF
Review Series

Central insulin action in energy and glucose homeostasis

  • Text
  • PDF
Abstract

Insulin has pleiotropic biological effects in virtually all tissues. However, the relevance of insulin signaling in peripheral tissues has been studied far more extensively than its role in the brain. An evolving body of evidence indicates that in the brain, insulin is involved in multiple regulatory mechanisms including neuronal survival, learning, and memory, as well as in regulation of energy homeostasis and reproductive endocrinology. Here we review insulin’s role as a central homeostatic signal with regard to energy and glucose homeostasis and discuss the mechanisms by which insulin communicates information about the body’s energy status to the brain. Particular emphasis is placed on the controversial current debate about the similarities and differences between hypothalamic insulin and leptin signaling at the molecular level.

Authors

Leona Plum, Bengt F. Belgardt, Jens C. Brüning

×

Figure 1

Insulin and leptin increase expression of POMC and decrease expression of AgRP.

Options: View larger image (or click on image) Download as PowerPoint
Insulin and leptin increase expression of POMC and decrease expression o...
Insulin binds to its receptor on POMC and AgRP neurons, stimulating receptor autophosphorylation and activating its signal cascade. IRS proteins bind to the phosphorylated residues on the IR and subsequently recruit the regulatory subunit p85 of PI3K. PI3K thereby becomes activated and phosphorylates phosphatidylinositol-4,5-bisphosphate (PIP2) on position 3′ in the inositol ring, generating PIP3. The lipid phosphatase PTEN antagonizes this by dephosphorylating PIP3 to generate PIP2. The protein kinase B/AKT and phosphoinositide-dependent protein kinase 1 (PDK1) bind to PIP3 via their pleckstrin homology (PH) domains. AKT is readily phosphorylated and activated by PDK1. Phosphorylated AKT enters the nucleus, where it phosphorylates FOXO1. This leads to exclusion from the nucleus and thereby to inactivation of FOXO1. FOXO1 exerts different effects in POMC and AgRP neurons. In POMC neurons, it diminishes POMC transcription by recruiting Ncor and Hdac1 and by competing with binding sites for phosphorylated STAT3 in the promoter. By phosphorylating and excluding FOXO1 from the nucleus, insulin de-inhibits the promoter, thereby increasing POMC expression. In AgRP neurons, FOXO1 increases AgRP transcription. Here insulin decreases FOXO1-mediated transcription of AgRP by excluding FOXO1 from the nucleus. Leptin binds to its receptor, leading to recruitment of JAKs, which phosphorylate the receptor. The STAT3 monomer binds to the activated leptin receptor and is phosphorylated by JAKs. Upon phosphorylation, two STATs homodimerize and translocate to the nucleus, where they activate POMC transcription in POMC neurons and decrease AgRP transcription in AgRP neurons. It is possible that leptin also induces activation of PI3K. Consequently, insulin de-inhibits and leptin activates the POMC promoter. Insulin deactivates and leptin inhibits the AgRP promoter.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts